Personnel at the Warren, New Jersey, plant concluded that several out-of-specification outcomes were due to analyst or instrument error and that the company did not document “evaluations of all the possible causes of the OOS results.”

— One conclusion from an FDA warning letter to Cordis concerning its manufacturing operations. “Congress to examine FDA’s handling of Cordis violations,” pp. 1, 7.